Skip to the content

pharmaceutical daily

Pharmaceuticals, Biotechnology and Life Sciences

  • HOME
  • Pharma Business
  • About us
    • Media Kit
    • Privacy Policy
  • Contact
May 6, 2019 Off

GlycoMimetics, Inc. Announces Enrollment Completed for Phase 3 Clinical Trial Evaluating Rivipansel in Sickle Cell Disease

By BusinessWire

ROCKVILLE, Md.–(BUSINESS WIRE)–GlycoMimetics, Inc. (Nasdaq: GLYC) today announced that patient enrollment has been completed in the Phase 3 RESET (Rivipansel:…

May 6, 2019 Off

Global CRISPR and CAS Gene Market to Surpass US$ 7,603.8 million by 2026

By BusinessWire

SEATTLE–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/CAS?src=hash" target="_blank"gt;#CASlt;/agt;–According to Coherent Market Insights, the global CRISPR and CAS gene Market was valued at US$ 1,388.1…

May 6, 2019 Off

Propanc Biopharma Appoints Dr. Ralf Brandt to its Scientific Advisory Board

By BusinessWire

Dr. Brandt to Provide Translational Research Expertise and Clinical Support Advisory Services MELBOURNE, Australia–(BUSINESS WIRE)–Propanc Biopharma, Inc. (OTCQB: PPCB) (“Propanc”),…

May 6, 2019 Off

Urovant Sciences Presents Positive Pivotal Data for Vibegron During Plenary Session at American Urological Association Annual Meeting

By BusinessWire

Pivotal Phase 3 EMPOWUR study met both co-primary endpoints, with significant reduction in daily urge urinary incontinence episodes and micturitions,…

May 6, 2019 Off

BioTime Announces Issuance of U.S. Patent for Method of Reducing Cavitation in Patients with Acute Spinal Cord Injury

By BusinessWire

ALAMEDA, Calif.–(BUSINESS WIRE)–lt;a href="https://twitter.com/search?q=%24BTX&src=ctag" target="_blank"gt;$BTXlt;/agt; lt;a href="https://twitter.com/hashtag/SCI?src=hash" target="_blank"gt;#SCIlt;/agt;–BioTime, Inc. (NYSE American and TASE: BTX), a clinical-stage biotechnology company developing cellular…

May 6, 2019 Off

Initial Data for Alterity Therapeutics Phase 1 Clinical Trial Released at American Academy of Neurology Annual Meeting

By BusinessWire

MELBOURNE, Australia AND SAN FRANCISCO–(BUSINESS WIRE)–Alterity Therapeutics Limited (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”) is today releasing interim…

May 6, 2019 Off

Progenity to Showcase New Data at Digestive Disease Week®

By BusinessWire

SAN DIEGO–(BUSINESS WIRE)–Progenity, Inc., a privately held biotechnology company developing precision medicine solutions across genomic/epigenomic, proteomic, and microbiomic diagnostic and…

May 6, 2019 Off

New Metabolic Biomarkers Open Door to Earlier Diagnosis, More Precise and Individualized Treatment of Children at Risk for Autism

By BusinessWire

NeuroPointDX Presents Further Data from Children’s Autism Metabolome Project at INSAR 2019 MADISON, Wis.–(BUSINESS WIRE)–Continued analysis of samples from the…

May 6, 2019 Off

Moderna to Present at Bank of America Merrill Lynch 2019 Health Care Conference

By BusinessWire

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Moderna, Inc., (Nasdaq: MRNA) a clinical stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create…

May 6, 2019 Off

Acerus to Report First Quarter 2019 Financial Results and Host Investor Call

By BusinessWire

TORONTO–(BUSINESS WIRE)–Acerus Pharmaceuticals Corporation (TSX:ASP) will announce its first quarter 2019 financial and operating results on Monday May 13, 2019…

Posts pagination

Previous 1 … 3,223 3,224 3,225 … 3,606 Next

JOIN OUR COMMUNITY

Proudly powered by WordPress | Theme: Envo Magazine